Global Expansion Avalere Health is actively expanding its global footprint with new strategic offerings and cross-border capabilities, signaling opportunities to position services for multinational biopharma and medical tech clients seeking end-to-end product lifecycle support.

Strategic Offerings Recent launch of strategic offerings, including end-to-end support for Japanese biopharma companies and revenue-driving patient access initiatives, creates openings to upsell integrated consulting, policy, access, value and evidence, and digital experience services.

Patient Access Focus Avalere’s emphasis on patient access programs, CGP pathways, and interactive guides indicates demand for market access consulting, health economics and outcomes research, and payer strategy to accelerate adoption of genomic-based therapies.

Policy Leadership New senior hires in policy leadership and public health leadership signal a strengthening of government affairs and policy impact capabilities, offering a path to sell comprehensive policy, reimbursement, and regulatory strategy services to biopharma and life sciences clients.

Industry Collaboration Active participation in industry forums and co-signed operating models at events with major pharma players suggests a fertile channel for joint marketing, advisory, and digital experience technology solutions to scale with partner ecosystems.